4-165379284-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001873.4(CPE):c.63G>T(p.Trp21Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000115 in 1,479,482 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001873.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPE | NM_001873.4 | c.63G>T | p.Trp21Cys | missense_variant | 1/9 | ENST00000402744.9 | NP_001864.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPE | ENST00000402744.9 | c.63G>T | p.Trp21Cys | missense_variant | 1/9 | 1 | NM_001873.4 | ENSP00000386104.4 | ||
CPE | ENST00000513982.5 | c.-30+17973G>T | intron_variant | 4 | ENSP00000424830.1 | |||||
CPE | ENST00000480404.1 | n.-2G>T | upstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 151900Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000142 AC: 12AN: 84560Hom.: 0 AF XY: 0.000126 AC XY: 6AN XY: 47692
GnomAD4 exome AF: 0.000121 AC: 160AN: 1327582Hom.: 0 Cov.: 31 AF XY: 0.000127 AC XY: 83AN XY: 654416
GnomAD4 genome AF: 0.0000658 AC: 10AN: 151900Hom.: 0 Cov.: 32 AF XY: 0.0000674 AC XY: 5AN XY: 74200
ClinVar
Submissions by phenotype
CPE-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 24, 2024 | The CPE c.63G>T variant is predicted to result in the amino acid substitution p.Trp21Cys. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.028% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 10, 2023 | The c.63G>T (p.W21C) alteration is located in exon 1 (coding exon 1) of the CPE gene. This alteration results from a G to T substitution at nucleotide position 63, causing the tryptophan (W) at amino acid position 21 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at